Has David Gozansky, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,884 in general payments to David Gozansky, MD across 49 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Gozansky, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Gozansky, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Gozansky, MD

Internal Medicine · Ft Lauderdale, FLNPI 1013945591

Payments from drug & device makers

$1,884in general payments, 2019–2025

Across 49 payments — averaging $38.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$1K
Abbott$216
Novo Nordisk$66
Biosense Webster, Inc.$59
Amgen$57
Novartis$36
plus $52 from 2 others

What the payments were for

Food & beverage$1,879100%
Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	33	$1,397
Abbott	4	$216
Novo Nordisk	3	$66
Biosense Webster, Inc.	2	$59
Amgen	2	$57
Novartis	2	$36
GSK	2	$33
Astellas Pharma US Inc	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,884 in reported general payments places this provider in the 75th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$80,111

Medicare patients

164

Services billed

1,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	132	$127,782
OzempicSemaglutide	90	$86,391
EliquisApixaban	67	$74,688
FarxigaDapagliflozin Propanediol	65	$58,268
XareltoRivaroxaban	41	$47,156
MounjaroTirzepatide	41	$42,570
JanuviaSitagliptin Phosphate	20	$16,850
InvokanaCanagliflozin	12	$11,676
LokelmaSodium Zirconium Cyclosilicate	11	$9,280
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	12	$8,621
Atorvastatin Calcium	406	$3,501
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	56	$3,436
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	36	$3,343
SynthroidLevothyroxine Sodium	35	$2,542
Omeprazole	126	$2,491

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic	$66	$86,39190 claims
Johnson & JohnsonXarelto, Invokana	$1,397	$58,83253 claims
GSKTrelegy Ellipta	$33	$8,62112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,530 internal medicine providers in Florida.

Other internal medicine in Ft Lauderdale

Yaneicy Gonzalez RojasCoral Gables$93.5M
Juan Carlos RondonHollywood$66.8M
Jaynier MoyaPembroke Pines$45.4M
Mark KutnerMiami$35.7M
Gilberto JimenezHialeah$35.6M
Mira BaronWest Palm Beach$29.6M
William SanchezHialeah$28.9M
Nelia Sanchez-CrespoHollywood$28.8M
Kwabena AyesuOrlando$27.6M
Michael DeverWindermere$24M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →